The power and pitfalls of omics part 2: epigenomics, transcriptomics and ME/CFS
Simon McGrath concludes his blog about the remarkable Prof George Davey Smith's smart ideas for understanding diseases, which may soon be applied to ME/CFS.
Discuss the article on the Forums.

Transparency between Laboratories and patients

Discussion in 'General ME/CFS Discussion' started by ChrisD, Oct 31, 2017.

  1. ChrisD

    ChrisD Senior Member

    East Sussex
    Every day I sign into Phoenix Rising and Twitter in the hope of seeing great news about developments in ME research, either to be disappointed or pleasantly surprised - but mostly the former. I'm aware that there is work going on at Stanford/OMF, Columbia, Cornell, Griffith (Aus), Norway and probably many others but it would be really nice to know what kind of progress is being made.

    Wouldn't it be great if a bit like a technological development roadmap that outlines key dates and plans, we had something like that for medical research to know where everyone is at? I certainly understand that there is only so much that can be disclosed and labs only want to confirm findings once they are sure of them, but a bit of transparency would do wonders for the community in terms of hope and motivation.

    For example, the discovery that Activin B (I think in Aus) could be a biomarker for CFS diagnosis was promising for clinical care of ME, but now all has gone quiet on that front and it is just a case of waiting in the dark until the next update. Even then, we don't necessarily know if they are still working on this or if they have the correct funding and so on.

    Does anyone know where I am coming from on this?
    Skycloud, ScottTriGuy and ballard like this.

See more popular forum discussions.

Share This Page